Hemodialysis Access Complications during the first 30 days; Single Center Experience
DOI:
https://doi.org/10.54361/Keywords:
Hemodialysis catheter, double lumen catheter blockage, HD catheter infection, septicemiaAbstract
Background Temporary hemodialysis (HD) catheter is required mostly in acute and sometimes in chronic renal failure and in other cases. HD catheter is not free of complications. Aim of the study To assess the common complications occur during HD-catheter insertion and during the first 30-days of insertion. Method Two hundred-ten patients had temporary HD catheter been inserted in Tripoli Central Hospital and other private clinics in Tripoli. Patients had questionnaire that prepared about the complications. Patients were divided into three groups according to the site of HD catheter insertion at presentation. The complications detected by patients and/or following up doctors reported in the same questionnaire sheet. The data was collected at the end of 30 days after HD-catheter insertion and analyzed for demographic patients feature, and the complications reported at insertion and during the first 30 days. Statistical analysis Frequency and percentage of commonly occurred complications were analyzed by IBM-SPSS statistical package version 18 program (SPSS inc., Chicago III, USA). Results Included patients were divided into three groups. Group A: 95 patients had catheter at the jugular veins. Group B: 73 patients had femoral vein canalization, and group C: 42 patients had subclavian vein catheterization. Group A were 65 male and 30 female patients, group B were 42 males and 31 females, and group C had 30 males, and 12 females. Patients mean age was 55.1 years ± 5.12 and (22 – 68) years of age. Patients included in the study were randomly allocated into the three groups as they were presented. Pain at the site of insertion and during the first 12 hours was the commonest complications (72.9%), and pain around the insertion site during the first 12 hours reported by 102 (48.6%) patients. Infection at the site of insertion reported in 38.6% of patients. Femoral vein catheterization entrance site infection reported in 45 (55.6%), at subclavian reported in 15 (18.5%) and at jugular veins in 21 (25.9%) patients. Catheter tunnel infection was reported in 11 (5.2%) patients. Catheter tunnel infection was reported more with femoral catheter. Arterial or venous HD catheter lumen blockage reported in 46 (21.9%). Two lumens blockage reported in 61 (29%) patients. Bleeding from the entrance site of the catheter reported during HD sessions reported in 10 (4.8%) patients. Hematoma at insertion site or around it was reported in 52 (24.8%) patients. It was more after femoral vein catheterization 28 (53.8%) followed by jugular 18 (34.6%) and then subclavian catheterization 6 (11.5%) patients. Conclusion Pain and infection at the insertion site were the commonest complications of HD catheter insertion. Reducing the rate of these complications depends mainly upon implanting strict septic techniques, and train doctors and nurses about HD insertion complications and
References
Pozzoni P, Del Vecchio L, Pontoriero G, Di Filippo S, Locatelli F (2004). Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol. 7: 87–95.
Ravani P, Marcelli D, Malberti F (2002). Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistula for hemodialysis. Am J Kidney Dis. 40:1264–1276.
Daugirdas JT, Blake PG, Ing TS (2001.). Vascular access for hemodialysis. Handbook of Dialysis 3rd edn. Philadelphia: Lippincott & Wilkins.
Montagnac R, Bernard C, Guillaume J, Hanhart P, Clavel P, Yazji J, Martinez LM, Schillinger F (1997). Femoral indwelling silicone catheter experience of three hemodialysis centers. Nephrol Dial Transplant. 12: 772–775.
Dhingra RK.,Young EW.,Hulbert-Shearon TE.,Leavey SF.,Port FK (2001). Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 60: 1443-1451
Roy-Chaudhury P, Duncan H, Barrett W, Elson H, Narayana A, Foley J, Misra S, Lynch PM, Zuckerman D (2003). Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need. J Invasive Cardiol. 15 Suppl A:25–30.
Hung KY, Tsai TJ, Yen CJ, Yen TS (1995) Infection associated with reference double lumen catheterization for temporary hemodialysis: Experience of 168 cases. Nephrol Dial Transplant. 10:247–251.
Kite P, Dobbins BM, Wilcox MH, Fawley WN, Kindon AJ, Thomas D (1997). Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J Clin Pathol. 50:278–282..
Oliver M, Callery SM, Thope KE, Schwab SJ, Churchill DN (2000). Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use, a prospective study. Kidney Int. 58(6). 2543-2545.
Bolz K. D., Fjermeros G., Wideroe T. E., and Hatlinghus S (1995). Catheter malfunction and thrombus formation on double-lumen hemodialysis catheters: an intravascular ultrasonographic study. Am. J Kidney Dis. 25(4). 597–602.
Rao GM (1992) Diabetes mellitus in Libya: a retrospective study. Indian J Med Sci. 46(6):174–181.
Roaeid RB, Kablan AA (2010). Diabetes mortality and causes of death in Benghazi: a 5-year retrospective analysis of death certificates. East Mediterr Health J. 16(1):65–69.
Kadiki OA, Roaeid RB (2001): Prevalence of diabetes mellitus and impaired glucose tolerance in Benghazi Libya. Diabetes Metab. 27(6):647–654.
WHO: Eastern Mediterranean Regional Health Systems Observatory-Health Systems Profile- Libya. WHO: 2007. http://www.emro.who.int. Accessed December 201.
Salam AA, Alshekteria AA, Abd Alhadi H, Ahmed M, Mohammed A (2010): Patient satisfaction with quality of primary health care in Benghazi, Libya. Libyan J Med . 5- 8.
Usta A, Shawish T, Mishra A, Ehtuish EF, Ajaj H, Milud N, Shebani A,Abdulmola T, Tejori U (2008). Living related kidney transplantation in Libya: a single center experience. Transplant Proc. 40(10):3428–3433.
Ehtuish EF, Abouna GM, Shebani AH, Abdulmola TS, Shawesh TZ (2006). Kidney transplantation in Libya and North African and Middle Eastern perspective. Exp Clin Transplant. 4(1):425–428.
Abboud O (2006). Incidence, prevalence, and treatment of end-stage renal disease in the Middle East. Ethn Dis. 16(2 Suppl 2):S2-2-4.
Najafi I (2009). Peritoneal dialysis in Iran and the Middle East. Perit Dial Int. 29(Suppl 2):S217–S221.
Alashek WA, McIntyre CW, Taal MW (2011). Provision and quality of dialysis services in Libya. Hemodial Int. 15(4):444–452.
Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL (2008). Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 23:3219–3226.
Vazquez MA (2009): Vascular access for dialysis: recent lessons and new insights. Curr Opin Nephrol Hypertens. 18:116–121.
Akoh JA (2011): Vascular access infections: epidemiology, diagnosis, and management. Curr Infect Dis Rep. 13:324–332.
Lok CE (2007). Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2007, 2:1043–1053.
Kai W, Pei W, Xianhui L, Xiaoqing L, Zhangsuo L (2015). Epidemiology of hemodialysis catheter complications: a survey of 865 dialysis patients from 14 hemodialysis centers in Henan province in China. BMJ Open. 5(11):1-13.
Stevens PE, Levin A (2013). Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of Internal Medicine. 158:825–30.
Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GF, James MT (2013). Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 24:465–73.
Lacson EJ, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM (2007). Balancing fistula first with catheters last. Am J Kidney Dis. 50:379–95.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Habas Elmukhtar, Emsad Salha, Kanonie Wadie (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.